Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase
- PMID: 7613473
- PMCID: PMC2143096
- DOI: 10.1002/pro.5560040415
Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase
Abstract
Saposin C is a sphingolipid activator protein of 8.5 kDa that activates lysosomal glucocerebrosidase. Previously, we synthesized and characterized a synthetic full-length human saposin C protein that displays 85% of the activity of the native saposin C. In this study we use shorter synthetic peptides derived from the saposin C sequence to map binding and activation sites. By determining the activity and kinetic constant (Kact) values of these peptides, we have identified two functional domains, each comprising a binding site adjacent to or partially overlapping with an activation site. Domains 1 and 2 are located within amino acid positions 6-34 and 41-60, respectively. The activation sites span residues 27-34 and 41-49, whereas binding sites encompass residues 6-27 and 45-60. Peptides containing the sequences of either domain displayed 90% of the activity of the full-length synthetic saposin C. Domain 2, however, bound to glucocerebrosidase by at least an order of magnitude more strongly than domain 1. Binding sites within these domains contain sequences that are excellent candidates for forming amphipathic helical structures. Competition assays demonstrated that the binding of one domain to glucocerebrosidase prevents binding of the other domain, and that saposin A and saposin C bind to the same sites on glucocerebrosidase. A model predicting a saposin C:glucocerebrosidase complex with a stoichiometry of 4:2, respectively, is presented.
Similar articles
-
Synthesis and characterization of a bioactive 82-residue sphingolipid activator protein, saposin C.J Mol Neurosci. 1993 Fall;4(3):161-72. doi: 10.1007/BF02782499. J Mol Neurosci. 1993. PMID: 8292489
-
Saposin A: second cerebrosidase activator protein.Proc Natl Acad Sci U S A. 1989 May;86(9):3389-93. doi: 10.1073/pnas.86.9.3389. Proc Natl Acad Sci U S A. 1989. PMID: 2717620 Free PMC article.
-
Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides.J Biol Chem. 1994 Aug 12;269(32):20528-32. J Biol Chem. 1994. PMID: 8051151
-
The immunological functions of saposins.Adv Immunol. 2010;105:25-62. doi: 10.1016/S0065-2776(10)05002-9. Adv Immunol. 2010. PMID: 20510729 Free PMC article. Review.
-
Mutations causing Gaucher disease.Hum Mutat. 1994;3(1):1-11. doi: 10.1002/humu.1380030102. Hum Mutat. 1994. PMID: 8118460 Review.
Cited by
-
Engineering of Saposin C Protein Chimeras for Enhanced Cytotoxicity and Optimized Liposome Binding Capability.Pharmaceutics. 2021 Apr 19;13(4):583. doi: 10.3390/pharmaceutics13040583. Pharmaceutics. 2021. PMID: 33921905 Free PMC article.
-
Reply to Graham et al.: In silico atomistic coordinates and molecular dynamics simulation trajectories of the glucocerebrosidase-saposin C complex.Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11101-11102. doi: 10.1073/pnas.1905744116. Proc Natl Acad Sci U S A. 2019. PMID: 31164477 Free PMC article. No abstract available.
-
A Guided Tour of the Structural Biology of Gaucher Disease: Acid-β-Glucosidase and Saposin C.Enzyme Res. 2011;2011:973231. doi: 10.4061/2011/973231. Epub 2011 Nov 22. Enzyme Res. 2011. PMID: 22145077 Free PMC article.
-
The role of saposin C in Gaucher disease.Mol Genet Metab. 2012 Jul;106(3):257-63. doi: 10.1016/j.ymgme.2012.04.024. Epub 2012 May 5. Mol Genet Metab. 2012. PMID: 22652185 Free PMC article. Review.
-
Saposin C protects glucocerebrosidase against α-synuclein inhibition.Biochemistry. 2013 Oct 15;52(41):7161-3. doi: 10.1021/bi401191v. Epub 2013 Oct 1. Biochemistry. 2013. PMID: 24070323 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources